クイックアンサー — セランクとは何ですか?
Selank is a 7-amino-acid synthetic heptapeptide developed at the Russian Academy of Sciences as an analog of the endogenous immunomodulatory peptide tuftsin. In published studies it acts as an anxiolytic nootropic, modulating GABAergic, serotonergic, and enkephalin signalling and upregulating BDNF expression without the sedation or dependence profile of benzodiazepines. Supplied in 5 mg and 10 mg lyophilized vials.
📦 すべてのご注文は、当店の 再発送保証ポリシー — 万が一、20営業日以内に商品が届かない場合は、再発送いたします。
| 仕様 | 詳細 |
|---|---|
| CAS番号 | 129954-34-3 |
| 分子式 | C33H57N11O9 |
| 分子量 | 751.88 Da |
| 配列 | Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2 (TKPRPGP-NH2, 、7アミノ酸からなるC末端アミド化タフトシン類似体) |
| 形態 | 凍結乾燥粉末(白色〜微黄色) |
| 純度 | ≥99%(HPLC検証済み、COAはご要望に応じて提供) |
| 保管方法 | 凍結乾燥品:使用時在庫は2~8℃(冷蔵)に保管。未開封バイアルの長期保管には−20℃。再溶解後:2~8℃で約30日以内に使用。光から保護してください。再溶解液の凍結融解は避けてください。 |
| 溶解性 | Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations. |
Selank(セランク)とは何ですか?
Selank is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same clinical that developed Semax. It is structurally an analog of the endogenous immunomodulatory tetrapeptide tuftsin (TKPR), extended at the C-terminus with a Pro-Gly-Pro tail that confers proteolytic stability and an amidated C-terminus. The tail extension dramatically extends plasma half-life relative to native tuftsin, which is degraded within minutes, while preserving the immunomodulatory activity of the parent peptide. Selank’s well-characterised sequence is TKPRPGP-NH2, 、分子量751.88 Da、実験式C33H57N11O9. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. In Russia, Selank is approved as a prescription anxiolytic under the name Selank (intranasal spray); outside the post-Soviet bloc it is not approved by the FDA, EMA, MHRA, or any other major regulator. For sister-peptide studies, see our Semax 製品ページをご覧ください。
作用機序 — GABA作動性、セロトニン作動性、BDNF経路
What makes Selank distinctive among anxiolytic compounds is its 多経路の神経調節プロファイル GABA・ベンゾジアゼピン受容体部位への直接結合なしに作用し — それぞれが公開研究で観察される抗不安および向知性表現型に寄与しています:A benzodiazepine site — each contributing to the observed anxiolytic and nootropic phenotype in published studies:
- ベンゾジアゼピン結合部位を介さないGABA作動性調節 — Selank potentiates GABA-mediated inhibition through allosteric effects distinct from the benzodiazepine binding pocket. In rodent study models it raises seizure threshold and produces anxiolysis on elevated-plus-maze and open-field tests, but without the sedation, motor coordination loss, dependence liability, or rebound anxiety seen with diazepam. This distinct mode of GABA modulation is the most-studied aspect of Selank’s pharmacology.
- セロトニン作動性およびエンケファリン作動性シグナル伝達 — Published studies has documented increased serotonin metabolism (5-HIAA / 5-HT ratio) in cortical and limbic regions following Selank administration in rodents, alongside upregulation of enkephalin gene expression. The combined serotonergic and enkephalinergic signal is thought to contribute to mood-modulatory and stress-resilience effects in chronic-stress study models.
- BDNF発現と神経可塑性 — Selank raises brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex in published studies, a mechanism increasingly recognised as central to the long-term effects of mood-modulatory compounds. BDNF upregulation also underpins Selank’s nootropic profile — improved memory consolidation and learning performance in rodent maze tasks.
Selank is intranasally bioavailable (one of the very few peptides with documented mucosal absorption), which is the primary administration route in published Russian and Eastern European studies. The intranasal route bypasses first-pass metabolism and delivers peptide directly across the cribriform plate into central compartments, producing CNS effects within minutes of administration. Subcutaneous administration is also documented in preclinical studies and produces a similar pharmacological profile with slightly slower onset.
Published Evidence
Selank is used in clinical contexts that investigate:
- 抗不安薬理学 — 全般性不安のげっ歯類モデルにおける高架式十字迷路試験、オープンフィールド試験、社会相互作用試験;ベンゾジアゼピン(ジアゼパム)およびSSRIとの比較群(Kozlovskaya et al., Eksp Klin Farmakol; Inozemtsev et al., Bull Exp Biol Med)
- Stress resilience and HPA-axis studies — 慢性軽度ストレス、拘束ストレス、学習性無力感モデル、コルチゾールとACTHの動態
- BDNF and neuroplasticity studies — 海馬および前頭前皮質におけるBDNF発現、樹状突起スパイン形態、長期増強の電気生理学
- Cognitive and memory studies — モリス水迷路、新奇物体認識試験、受動的回避試験、抗不安作用とは独立した向知性効果
- 免疫調節作用 — Selank inherits tuftsin’s immunomodulatory activity, with documented effects on cytokine balance (TNF-α, IL-6, IFN-γ) and macrophage function in published studies
- Comparative studies vs benzodiazepines — 抗不安効果、依存性リスク、リバウンドに関してジアゼパム、アルプラゾラム、フェナゼパムと直接比較;Selankの離脱症状の少なさはロシア文献で最も頻繁に引用される知見の一つである
- Sister-peptide studies — ベンチマーク比較 Semax (a sister heptapeptide from the same clinical) for nootropic and neuroprotective effects.
For broader context on small-peptide neuromodulation and nootropic studies, see Semax ロシアで開発された標準的な向知性薬の比較対象として、, Epitalon for pineal-peptide longevity studies, and BPC-157 for the parallel small-peptide healing-compound. Browse the full ペプチドカタログ 化合物選択のために。
利用可能な力価と濃度
MedsBase stocks Selank in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:
| バイアル力価 | 代表的な使用例 | パックサイズ |
|---|---|---|
| 5 mg | Short protocols, pilot dosing, intranasal-vehicle formulation studies | 10、20、または30バイアル |
| 10 mg | Standard strength, extended protocols, lowest per-mg cost | 10、20、または30バイアル |
Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection or intranasal-delivery volume in rodent protocols.
比較 — SelankとSemax
Selankと Semax are sister peptides developed at the same Russian clinical (Institute of Molecular Genetics, Russian Academy of Sciences) and are often compared in studies because they share heptapeptide architecture, intranasal bioavailability, and Russian regulatory history but differ substantially in primary pharmacological action. Selank is the canonical anxiolytic of the pair; Semax is the canonical nootropic/neuroprotective.
| 評価項目 | Selank | Semax |
|---|---|---|
| アミノ酸数 | 7アミノ酸(ヘプタペプチド) | 7アミノ酸(ヘプタペプチド) |
| 親ペプチド | タフトシン(TKPR) | ACTH(4-10)フラグメント |
| 主な作用機序 | GABA調節、BDNF、エンケファリン | BDNF、メラノコルチン受容体、ドーパミン |
| Primary signal | 抗不安作用、ストレス耐性 | 認知機能向上、神経保護、集中力 |
| Typical dose (intranasal) | 300~900 mcg/日 | 200~1,000 mcg/日 |
| ロシアでの臨床使用 | 承認済み抗不安薬(経鼻) | 承認済み認知機能改善薬/脳卒中回復(経鼻) |
| Stacking in studies | Semaxと頻繁に併用し、抗不安+認知機能向上の相補効果を発揮 | Selankと頻繁に併用 |
Because the two peptides act on complementary axes — Selank on GABA/anxiolytic, Semax on melanocortin/dopaminergic/nootropic — they are frequently co-administered in protocols investigating cognitive performance under stress, where both arms (calm and focus) contribute to the studied phenotype.
保管方法と再溶解
再溶解前: 凍結乾燥バイアルは、短期作業用として、元の包装のまま2~8°Cで冷蔵保存してください。未開封の長期保存の場合は、−20°Cで冷凍保存してください。凍結乾燥セランフは、冷蔵で最長24ヶ月、−20°Cで最長36ヶ月間安定です。凍結乾燥粉末の凍結融解サイクルを避けてください。 再溶解手順: inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5 mg vial, 1.0 mL of bacteriostatic water yields a 5 mg/mL working concentration; 0.1 mL delivers a 500 mcg dose. Swirl gently — do しません shake — and allow 2–5 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100 μL per pump. 完全に再溶解した溶液は、無色透明である必要があります。 最適な安定性のため、2~8°Cで冷蔵保存し、30日以内に使用してください。再構成溶液を凍結しないでください — 凍結融解サイクルはペプチドの完全性を劣化させます。白濁、沈殿、または変色が見られるバイアルは廃棄してください。
よくある質問
What is Selank used for in studies?
Selank is used in studies investigating anxiolytic pharmacology, stress resilience, BDNF and neuroplasticity, cognitive performance, immunomodulation, and head-to-head comparison against benzodiazepines. It is the most-cited Russian-developed anxiolytic peptide in the literature. The pharmaceutical-grade Selank sold here is しません FDA-approved and is supplied strictly for clinical studies use only.
セランフはセマックスとどのように異なりますか?
Both are 7-amino-acid heptapeptides from the same Russian clinical and share intranasal bioavailability, but their mechanisms differ. Selank is derived from the immunomodulatory peptide tuftsin and acts predominantly via GABAergic, enkephalinergic, and BDNF pathways — canonical arm: anxiolysis. Semax is derived from ACTH(4-10) and acts via melanocortin receptors, BDNF, and dopaminergic modulation — canonical arm: nootropic and neuroprotection. The two are frequently co-administered in studies because the effects are complementary rather than overlapping.
What is the typical Selank dose?
Published Russian protocols typically use 300–900 mcg per day administered intranasally in 3 divided doses, or equivalent subcutaneous doses. A 5 mg vial reconstituted with 1.0 mL bacteriostatic water yields 5 mg/mL — 0.1 mL equals 500 mcg, a typical single-dose studies aliquot.
セランフはFDA承認されていますか?
No. Selank is not approved by the FDA, EMA, MHRA, or any major Western regulator. It is approved in Russia as a prescription anxiolytic under the brand name Selank (intranasal spray, ZAO Pharm-Sintez).
セランフはどのように保存すべきですか?
凍結乾燥バイアル:短期使用の作業用ストックは2~8°Cで冷蔵保存、未開封バイアルの長期保存は-20°Cで保管してください。再溶解後の溶液:2~8°Cで冷蔵保存し、30日以内に使用してください。再溶解後の溶液は凍結しないでください。凍結融解サイクルによりペプチドが分解されます。常に直射光を避けて保護してください。
セランフをどのように再構成しますか?
上記の再溶解手順に従ってください。注射用静菌水をバイアルの内壁に沿って(凍結乾燥ケーキに直接当てないように)加え、静かに旋回させ、完全に溶解するまで2~5分間置きます。 しません バイアルを振ってください。正しく再構成された溶液は無色透明です。5 mgバイアル+1.0 mLの希釈液の場合、作業濃度は5 mg/mLです。
MedsBaseではどの容量のレタルトルチドを取り揃えていますか?
MedsBase carries Selank in 5 mg and 10 mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request.
Can Selank be administered intranasally in studies?
Yes — intranasal administration is the primary administration route in Russian and Eastern European published studies. Selank is one of the few peptides with documented intranasal bioavailability, attributable to its small size (7 aa, ~752 Da) and amidated C-terminus. The route bypasses first-pass metabolism and delivers peptide across the cribriform plate into central compartments within minutes of administration. Subcutaneous and intramuscular routes also work in preclinical models.
Can Selank and Semax be stacked in studies?
Yes. Selank and Semax are frequently co-administered in published studies because their mechanisms are complementary. Selank provides anxiolytic and stress-buffering effects via GABA/enkephalin/BDNF pathways; Semax provides nootropic and neuroprotective effects via melanocortin/dopaminergic/BDNF pathways. The combination is particularly studied in study models of cognitive performance under stress.
Does Selank cause side reported effects?
Published preclinical and Russian clinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation — in clear contrast to benzodiazepine comparator arms. Long-term safety data outside Russia is limited because the peptide has not undergone Western regulatory review.
Selankの半減期はどのくらいですか?
In preclinical studies, Selank has an estimated plasma half-life of approximately 15–30 minutes following intranasal administration, far longer than the parent peptide tuftsin (under 5 minutes). The short plasma half-life is offset by central-compartment accumulation following intranasal delivery and downstream effects on BDNF and gene expression that persist beyond plasma clearance.
How long does Selank take to show effects in preclinical studies?
Acute anxiolytic effects on elevated-plus-maze and open-field tests are detectable within 30–60 minutes of intranasal administration. BDNF and gene-expression effects accumulate over 7–14 days of regular dosing and underpin the longer-term mood-modulatory and nootropic phenotype observed in chronic-stress study models.
Selankは全世界配送で注文できますか?
Yes. MedsBase ships Selank worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. All orders ship in temperature-controlled packaging with full tracking and are covered by our 再発送保証ポリシー.
Other Peptides for Nootropic, Neuroprotective, and Cognitive Studies
- Semax — Sister heptapeptide from the same Russian clinical — nootropic and neuroprotective studies
- Epitalon — AEDG pineal tetrapeptide — longevity and circadian rhythm support
- BPC-157 — Body Protection Compound — healing and tissue-recovery
- KPV — Small immunomodulatory tripeptide — inflammation and barrier studies
- Adamax — Heptapeptide nootropic compound













レビュー
まだレビューはありません